Abiopharma

🔍 Basi Ramitpal K (Executive)

Company: INCYTE CORP (INCY)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 504 shares of Common Stock at $129.72 per share (Direct)
  Date: 2026-08-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,993.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
• F2: This includes an aggregate of 9,871 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.